Associated Papers
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D.
Yang X et al.
Journal of the National Cancer Institute, 2020
32107557 (PubMed )
Supplement: djaa030_supplementary_data.pdf
Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Loveday C et al.
Nature Genetics, 2011
Select a paper to view details